HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Mechanism of action of nonachlazine and ethmozine on the cardiac blood supply in acute myocardial ischemia].

Abstract
In anesthetized cats, intravenous administration of nonachlazin (1 and 6 mg/kg) and ethmozine (2 and 5 mg/kg) led, 5 minutes after ligation of the anterior descending branch of the left coronary artery, to the increased blood outflow from the coronary sinus and to a less marked elevation of myocardial oxygen consumption. The coronarodilatory effect of the drugs fell in the presence of a preliminary injection of the sympatholytic octadin (25 mg/kg intraperitoneally), atropine (0.5 mg/kg intravenously), alpha-adrenoblocker dihydroergotoxin (2 mg/kg intravenously), and beta-adrenoblocker obsidan (0.5 mg/kg intravenously). Nonachlazin and ethmozine decreased the pituitrin-induced (2 ED/kg intravenously) spasm of the coronary vessels of the affected heart.
AuthorsD B Pilipchuk
JournalFarmakologiia i toksikologiia (Farmakol Toksikol) 1981 Jan-Feb Vol. 44 Issue 1 Pg. 63-7 ISSN: 0014-8318 [Print] Russia (Federation)
Vernacular TitleK mekhanizmu deĭstviia nonakhlazina i étmozina na krovosnabzhenie serdtsa pri ostroĭ ishemii miokarda.
PMID7021174 (Publication Type: Comparative Study, English Abstract, Journal Article)
Chemical References
  • Morpholines
  • Phenothiazines
  • Moricizine
  • Nonachlazine
Topics
  • Acute Disease
  • Animals
  • Cats
  • Coronary Circulation
  • Coronary Disease (drug therapy, metabolism, physiopathology)
  • Female
  • Male
  • Moricizine
  • Morpholines (therapeutic use)
  • Myocardium (metabolism)
  • Nonachlazine (therapeutic use)
  • Oxygen Consumption
  • Phenothiazines (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: